Latest news

CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity

Home
About
Portfolio
Pipeline
News
Contact

Menu

Home
About
Portfolio
Pipeline
News
Contact

Tag: Obesity Portfolio

CinFina Pharma In-Licenses Obesity Portfolio

CinFina Pharma announced that it has signed an agreement with Janssen Sciences.

Published September 22, 2021

Categorized as CinRx News Tagged CinFina Pharma, Obesity Portfolio

© 2024 CinRx Pharma. All Rights Reserved.

844-531-1834 | [email protected]

SITE PAGES

Home
About
Portfolio
Pipeline
News
Contact

Home
About
Portfolio
Pipeline
News
Contact

CINRX IN THE NEWS

CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity

March 26, 2024

CinPhloro Pharma, A CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for IBS-D

February 22, 2024

FOLLOW US

844-531-1834 | [email protected]

© 2023 CinRx Pharma. All Rights Reserved.

Home
About
Portfolio
Pipeline
News
Contact

Menu

Home
About
Portfolio
Pipeline
News
Contact

INVESTOR INQUIRIES

CAREER INQUIRIES

GENERAL INQUIRIES